Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01748305 · ClinicalTrials.gov registry record · NA

Moderate-to-vigorous Physical Activity for Glycemic Control in Patients With Gestational Diabetes Mellitus

A NA study, sponsored by Oregon Health and Science University.

Terminated
Registry status
NA
Development phase
14
Enrollment target

NCT01748305: Clinical Trial NA study, sponsored by Oregon Health and Science University.

NCT01748305 is a NA study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01748305, a NA study, was terminated before completion, sponsored by Oregon Health and Science University.

TERMINATED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

Patients with newly diagnosed gestational diabetes will be recruited. The control group with get routine diet and exercise counseling. The intervention group will be instructed to get moderate-to-vigorous intensity exercise; they will walk on a treadmill one time with supervision in order to be instructed how hard to work. All participants will keep an exercise log for 3 weeks and will wear an accelerometer for 1 week. The primary outcome is glucose control, specifically the need for medication in treatment of their diabetes. The hypothesis is that moderate or greater intensity exercise will better control glucose and lead to less need for medication management.

Interventions

  • BEHAVIORAL Moderate-to-vigorous intensity exercise

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2012-12
Est. Completion 2013-12
Phase NA

Why NCT01748305 stopped before completion

NCT01748305 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Moderate-to-vigorous intensity exercise is the first listed.

NCT01748305 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01748305 about?

NCT01748305 is a clinical study titled "Moderate-to-vigorous Physical Activity for Glycemic Control in Patients With Gestational Diabetes Mellitus". Patients with newly diagnosed gestational diabetes will be recruited. The control group with get routine diet and exercise counseling. The intervention group will be instructed to get moderate-to-vigorous intensity exercise; they will walk on a treadmill one time with supervision in order to be inst...

What is the current status of trial NCT01748305?

This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2012-12. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01748305?

The interventions under investigation include: Moderate-to-vigorous intensity exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01748305?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01748305's enrollment target sits among peer trials

14 1909th of 2000 higher than 90 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01748305, the US trial registry maintained by the National Library of Medicine. NCT01748305 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.